FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Device Industry Push Backֹ on UDI Standardized Date Format

[ Price : $8.95]

CDRH senior advisor for patient safety Jay Crowley says his Center is receiving push back from a number of global device makers on...

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Acu-International Supplies, Alere, Avon, Bioque Technologies, CellTex Therapeuti...

Celltex Warning Letter Up Regulates Cell Product

[ Price : $8.95]

An FDA Warning Letter lays out the basis for the agencys recent determination that Celltex Therapeutics stem cell product is subje...

CGMP Issues Found in Stat Rx Facility

[ Price : $8.95]

FDAs Atlanta District Office warns Stat Rx about CGMP violations in its drug repackaging/manufacturing facility.

FDA Pulls Texas IRB New Study OKs

[ Price : $8.95]

FDA warns Texas Applied Biomedical Services about continuing violations of IRB regulations and withholds approval of all new studi...

Inspection at DMC Finds Quality System Problems

[ Price : $8.95]

FDA warns DMC Medical Technology and Manufacturing Co. about Quality System Regulation violations in its manufacturing facility in...

CDRH eCopy Submissions Guidance

[ Price : $8.95]

A draft guidance outlines CDRHs electronic submission requirements mandated by the recently enacted Safety and Innovation Act.

Guidances on 510(k) and PMA Review Clock Actions Out

[ Price : $8.95]

FDA issues guidances on MDUFA 3 performance goals for PMAs and 510(k)s.

FDA, ArQule Reach SPA Agreement on Tivantinib

[ Price : $8.95]

FDA and ArQule reach agreement on a Special Protocol Assessment for the design of a pivotal Phase 3 trial involving tivantinib in ...

Accutron Recalls Ultra PC% Flowmeters

[ Price : $8.95]

FDA says Accutron is recalling its Ultra PC% flowmeters after receiving reports that two units flowed nitrous oxide without oxygen...